6,613
Total Claims
$1.1M
Drug Cost
410
Beneficiaries
$2,573
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-86%
Opioid rate vs peers
0.3% vs 2.2% avg
+82%
Cost per patient vs peers
$2,573 vs $1,411 avg
+55%
Brand preference vs peers
16.5% vs 10.6% avg
Opioid Prescribing
0.3%
Opioid Rate
20
Opioid Claims
$63
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
84% generic
Brand: 1,068 claims · $931K
Generic: 5,400 claims · $119K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 98 | $181K |
| Empagliflozin | 126 | $165K |
| Dapagliflozin Propanediol | 77 | $94K |
| Exenatide Microspheres | 47 | $58K |
| Apixaban | 45 | $49K |
| Sitagliptin Phosphate | 41 | $41K |
| Diclofenac Sodium | 15 | $40K |
| Calcipotriene/Betamethasone | 11 | $31K |
| Liraglutide | 19 | $24K |
| Linaclotide | 34 | $24K |
| Budesonide/Formoterol Fumarate | 22 | $15K |
| Sacubitril/Valsartan | 11 | $14K |
| Varicella-Zoster Ge/As01b/Pf | 61 | $12K |
| Sitagliptin Phos/Metformin Hcl | 18 | $12K |
| Insulin Glargine/Lixisenatide | 13 | $12K |
Prescribing Profile
Patient Profile
72
Avg Age
51%
Female
1.33
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About